Variant estrogen receptors and their role in liver disease

Molecular and Cellular Endocrinology

Volumn 193, Issue 1-2, 2002, Pages 65-69

  Villa, Erica ^a   Colantoni, Alessandra ^a,b   Grottola, Antonella ^a   Ferretti, Ilva ^a   Buttafoco, Paola ^a   Bertani, Helga ^a   De Maria, Nicola ^a   Manenti, Federico ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Antiestrogen; Estrogen receptors (ER); Hepatocellular carcinoma (HCC); Megestrol; Tamoxifen

Indexed keywords

ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MEGESTROL; TAMOXIFEN; RNA; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

APOPTOSIS; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; DNA BINDING; EXON; FEMALE; GENE DELETION; GENETIC TRANSCRIPTION; HISTOCHEMISTRY; HORMONE BINDING; HORMONE RESPONSE; HUMAN; HUMAN TISSUE; LIVER; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN VARIANT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WILD TYPE; ARTICLE; CELL DIVISION; DRUG EFFECT; GENETIC VARIABILITY; GENETICS; PATHOLOGY; PHYSIOLOGY; SURVIVAL;

APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL DIVISION; ESTROGEN RECEPTOR MODULATORS; EXONS; FEMALE; HUMANS; MALE; MEGESTROL; RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; SEQUENCE DELETION; SURVIVAL ANALYSIS; TAMOXIFEN; VARIATION (GENETICS);

EID: 0037205923     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(02)00097-7     Document Type: Conference Paper

References (29)

1. Nonsurgical treatment of hepatocellular carcinoma
2. Treatment of hepatocellular carcinoma with tamoxifen: a double-blind trial in 120 patients
3. Regression models and life tables (with discussion)
4. Rising incidence of hepatocellular carcinoma in the United States
5. Unresectable hepatocellular carcinoma. A prospective controlled trial with tamoxifen
6. Current treatment modalities for hepatocellular carcinoma
7. Alternative splicing of the estrogen receptor alfa
8. Inhibition of estrogen receptors action by naturally occurring variant in human breast tumors
9. Variant human breast tumor estrogen receptor with constitutive transcriptional activity
10. Effects of estrogens on thyroxine-binding globulin metabolism in Rhesus monkey
11. T4DCO cells, genetically unstable and containing estrogen receptors mutations, are a model for the progression of breast cancers to hormone resistance
12. Non-parametric estimation for incomplete observation
13. Early diagnosis and treatment of hepatocellular carcinoma
14. Tamoxifen improves survival in patients with advanced hepatocellular carcinoma
15. Estrogen receptors variants on clinical breast cancer
16. Estrogen receptors in hepatocellular carcinoma
17. Androgen and estrogen receptors in hepatocellular carcinoma and in the surrounding non-cancerous liver tissue
18. Natural history of hepatocellular carcinoma and prognosis in relation to treatment
19. Characterization and quantitation of human hepatic estrogen receptors
20. Defective estrogen receptors in human mammary cancers: their significance in defining hormone dependence
21. Characterization of estrogen receptors from human liver
22. Locoregional management of hepatocellular carcinoma. Surgical and ablation therapies
23. Truncated forms of DNA-binding estrogen receptors in human breast cancer
24. Hepatocellular carcinoma in the United States
25. Type of estrogen receptor determines response to antiestrogen therapy
26. Variant liver estrogen receptor transcripts already occur at an early stage of chronic liver disease
27. Natural history of inoperable hepatocellular carcinoma: estrogen receptor status in the tumor is the strongest prognostic factor for survival
28. Hormonal therapy with megestrol in inoperable hepatocellular carcinoma characterized by variant oestrogen receptors